<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39444963</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Respiratory pathogen analysis in pediatric inpatients unraveled the infection pattern of <i>Mycoplasma pneumoniae</i> post the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>1437508</StartPage><MedlinePgn>1437508</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1437508</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1437508</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">To counteract the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were implemented globally, exerting a profound influence on a wide spectrum of infectious diseases, encompassing respiratory tract infections (RTIs). Subsequent to the easing of NPIs, China experienced a significant outbreak of <i>Mycoplasma pneumoniae</i> (MP).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Over a decade from 2015 to 2024, our study scrutinized 12 common infectious diseases among pediatric children. Etiologically diagnostic data and clinical outcome metrics of children with RTIs, tested for 13 pathogens, were analyzed to evaluate changes during and after the pandemic compared to pre-pandemic periods, with a notable emphasis on age profile and coinfection patterns of MP.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 57,471 hospitalized children, 23,178 were diagnosed with infectious diseases. Under NPIs, most respiratory infections declined compared to pre-pandemic levels, rebounding by 69.64% in 2023. While the infection rate of common respiratory pathogens decreased, cases of respiratory syncytial virus increased during the period of extensive NPI implementation. In 2023, pediatric intensive care unit durations for these pathogens increased, suggesting greater severity of illness compared to 2019. MP exhibited the highest infection rate (31.38% average), with a notable outbreak post-pandemic due to severity increase in &lt;3 year olds and rise among older children. NPIs reduced MP coinfections and mitigated their severity, while exerting a significant influence on bacterial coinfections with MP over the span of 5 years, in contrast to their impact on viral pathogens.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">NPIs effectively curb transmission of respiratory infections by most pathogens, resulting in increased average age of MP infections and altered patterns of coinfection post-pandemic.</AbstractText><CopyrightInformation>Copyright © 2024 Chen, Xu, Gu, Peng, Ma, Su, Liu, Ge, Yang and Ning.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Qihong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Pediatric Key Laboratory of Xiamen, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Ruizhi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medical Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medical Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Peng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Pediatric Key Laboratory of Xiamen, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Chiyuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medical Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Dubin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medical Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medical Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Pediatric Key Laboratory of Xiamen, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yungang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Pediatric Key Laboratory of Xiamen, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Wanshan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medical Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009177" MajorTopicYN="Y">Mycoplasma pneumoniae</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">nonpharmaceutical interventions</Keyword><Keyword MajorTopicYN="N">respiratory pathogens</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39444963</ArticleId><ArticleId IdType="pmc">PMC11496064</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1437508</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim JH, Roh YH, Ahn JG, Kim MY, Huh K, Jung J, et al. . Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19. Int J Infect Dis. (2021) 110:29–35. doi: 10.1016/j.ijid.2021.07.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.005</ArticleId><ArticleId IdType="pubmed">34245886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L, Lin L, Zhang H, Wang Q, Cheng Y, Liu Q, et al. . Epidemiological and clinical characteristics of respiratory syncytial virus and influenza infections in hospitalized children before and during the COVID-19 pandemic in Central China. Influenza Other Respir Viruses. (2023) 17:e13103. doi: 10.1111/irv.13103, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13103</ArticleId><ArticleId IdType="pmc">PMC9895987</ArticleId><ArticleId IdType="pubmed">36824393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning W, Lei S, Yang J, Cao Y, Jiang P, Yang Q, et al. . Open resource of clinical data from patients with pneumonia for the prediction of COVID-19 outcomes via deep learning. Nat Biomed Eng. (2020) 4:1197–207. doi: 10.1038/s41551-020-00633-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-020-00633-5</ArticleId><ArticleId IdType="pmc">PMC7723858</ArticleId><ArticleId IdType="pubmed">33208927</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. (2022) 399:2047–64. doi: 10.1016/S0140-6736(22)00478-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00478-0</ArticleId><ArticleId IdType="pmc">PMC7613574</ArticleId><ArticleId IdType="pubmed">35598608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Xu D, Zhang Y, Wang T, Zhang L, Gu W, et al. . Epidemiological characteristics of four common respiratory viral infections in children. Virol J. (2021) 18:10. doi: 10.1186/s12985-020-01475-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01475-y</ArticleId><ArticleId IdType="pmc">PMC7787583</ArticleId><ArticleId IdType="pubmed">33407659</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. (2002) 2:25–32. doi: 10.1016/S1473-3099(01)00170-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(01)00170-0</ArticleId><ArticleId IdType="pubmed">11892493</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZJ, Yu LJ, Zhang HY, Shan CX, Lu QB, Zhang XA, et al. . Broad impacts of coronavirus disease 2019 (COVID-19) pandemic on acute respiratory infections in China: an observational study. Clin Infect Dis. (2022) 75:e1054–62. doi: 10.1093/cid/ciab942, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab942</ArticleId><ArticleId IdType="pmc">PMC8767888</ArticleId><ArticleId IdType="pubmed">34788811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao LW, Yin J, Hu YH, Liu XY, Feng XL, He JX, et al. . The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol Infect. (2019) 147:e192. doi: 10.1017/S0950268819000839, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268819000839</ArticleId><ArticleId IdType="pmc">PMC6518602</ArticleId><ArticleId IdType="pubmed">31364532</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur PM, Beeton ML. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae surveillance (MAPS) study group. Mycoplasma pneumoniae: Delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. (2024) 5:e100–1. doi: 10.1016/S2666-5247(23)00344-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00344-0</ArticleId><ArticleId IdType="pubmed">38008103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Li M, Luo M, Luo Q, Kang L, Xie H, et al. . Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infect. (2022) 11:1508–17. doi: 10.1080/22221751.2022.2078228, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2078228</ArticleId><ArticleId IdType="pmc">PMC9176688</ArticleId><ArticleId IdType="pubmed">35582916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XB, He W, Gui YH, Lu Q, Yin Y, Zhang JH, et al. . Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen. World J Pediatr. (2024) 20:5–10. doi: 10.1007/s12519-023-00793-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-023-00793-9</ArticleId><ArticleId IdType="pubmed">38231466</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens C, Clopper BR, DeVies J, Benitez A, McKeever ER, Johns D, et al. . Notes from the field: reemergence of Mycoplasma pneumoniae infections in children and adolescents after the COVID-19 pandemic, United States, 2018-2024. MMWR Morb Mortal Wkly Rep. (2024) 73:149–51. doi: 10.15585/mmwr.mm7307a3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7307a3</ArticleId><ArticleId IdType="pmc">PMC10899077</ArticleId><ArticleId IdType="pubmed">38386615</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C, Xue GH, Zhao HQ, Feng YL, Cui JH, Yuan J. Current status of Mycoplasma pneumoniae infection in China. World J Pediatr. (2024) 20:1–4. doi: 10.1007/s12519-023-00783-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-023-00783-x</ArticleId><ArticleId IdType="pmc">PMC10827902</ArticleId><ArticleId IdType="pubmed">38185707</ArticleId></ArticleIdList></Reference><Reference><Citation>De Francesco MA, Poiesi C, Gargiulo F. Coinfection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features. J Inf Secur. (2021) 82:e4–7. doi: 10.1016/j.jinf.2021.01.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.009</ArticleId><ArticleId IdType="pmc">PMC7816623</ArticleId><ArticleId IdType="pubmed">33482238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Xing Y, Shi L, Li W, Gao Y, Pan S, et al. . Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics. (2020) 146:e20200961. doi: 10.1542/peds.2020-0961</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0961</ArticleId><ArticleId IdType="pubmed">32376725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Lin L, Zhang N, Yang Y. Adenovirus and Mycoplasma pneumoniae coinfection as a risk factor for severe community-acquired pneumonia in children. Front Pediatr. (2024) 12:1337786. doi: 10.3389/fped.2024.1337786, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2024.1337786</ArticleId><ArticleId IdType="pmc">PMC10864498</ArticleId><ArticleId IdType="pubmed">38357505</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S, Koo S, Yang YJ, Lim HJ. Characteristics of the Mycoplasma pneumoniae epidemic from 2019 to 2020 in Korea: macrolide resistance and coinfection trends. Antibiotics (Basel). (2023) 12:1623. doi: 10.3390/antibiotics12111623, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12111623</ArticleId><ArticleId IdType="pmc">PMC10669541</ArticleId><ArticleId IdType="pubmed">37998825</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon Y, Lee HS, Yang J, Gwack J, Kim BI, Cha JO, et al. . Impact of nonpharmacological interventions on severe acute respiratory infections in children: from the National Surveillance Database. J Korean Med Sci. (2023) 38:e311. doi: 10.3346/jkms.2023.38.e311, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e311</ArticleId><ArticleId IdType="pmc">PMC10578990</ArticleId><ArticleId IdType="pubmed">37846785</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, et al. . Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. (2021) 70:1013–9. doi: 10.15585/mmwr.mm7029a1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiapinotto S, Sarria EE, Mocelin HT, Lima JAB, Mattiello R, Fischer GB. Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses. Paediatr Respir Rev. (2021) 39:3–8. doi: 10.1016/j.prrv.2021.04.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8074521</ArticleId><ArticleId IdType="pubmed">34016531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardsley M, Morbey RA, Hughes HE, Beck CR, Watson CH, Zhao H, et al. . Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. (2023) 23:56–66. doi: 10.1016/S1473-3099(22)00525-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00525-4</ArticleId><ArticleId IdType="pmc">PMC9762748</ArticleId><ArticleId IdType="pubmed">36063828</ArticleId></ArticleIdList></Reference><Reference><Citation>di Mattia G, Nenna R, Mancino E, Rizzo V, Pierangeli A, Villani A, et al. . During the COVID-19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol. (2021) 56:3106–9. doi: 10.1002/ppul.25582, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25582</ArticleId><ArticleId IdType="pmc">PMC8441855</ArticleId><ArticleId IdType="pubmed">34273135</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamm P, Sagoschen I, Weise K, Plachter B, Münzel T, Gori T, et al. . Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing. Med Microbiol Immunol. (2021) 210:277–82. doi: 10.1007/s00430-021-00720-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-021-00720-7</ArticleId><ArticleId IdType="pmc">PMC8487758</ArticleId><ArticleId IdType="pubmed">34604931</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu W, Zheng C, Huang S, Zhang Y, Chen Z. Epidemiological trend of RSV infection before and during COVID-19 pandemic: a three-year consecutive study in China. Infect Drug Resist. (2022) 15:6829–37. doi: 10.2147/IDR.S388231</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S388231</ArticleId><ArticleId IdType="pmc">PMC9717604</ArticleId><ArticleId IdType="pubmed">36465809</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Li L, Zhang H, Liu C, Li R, Wu X, et al. . The changing pattern of common respiratory viruses among children from 2018 to 2021 in Wuhan, China. Arch Virol. (2023) 168:291. doi: 10.1007/s00705-023-05891-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-023-05891-7</ArticleId><ArticleId IdType="pmc">PMC10645662</ArticleId><ArticleId IdType="pubmed">37962775</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Chen S, Lv M, Zhang Z, Wang Z, Shao X, et al. . Are we ready to face the next wave of RSV surge after the COVID-19 omicron pandemic in China? Front Cell Infect Microbiol. (2023) 13:1216536. doi: 10.3389/fcimb.2023.1216536, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1216536</ArticleId><ArticleId IdType="pmc">PMC10751930</ArticleId><ArticleId IdType="pubmed">38152122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Ye Y, Chen X, Xiong L, Xie W, Liu P. Insight into the pathogenic mechanism of Mycoplasma pneumoniae. Curr Microbiol. (2022) 80:14. doi: 10.1007/s00284-022-03103-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-022-03103-0</ArticleId><ArticleId IdType="pmc">PMC9716528</ArticleId><ArticleId IdType="pubmed">36459213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Kumar S. Mycoplasma pneumoniae: among the smallest bacterial pathogens with great clinical significance in children. Indian J Med Microbiol. (2023) 46:100480. doi: 10.1016/j.ijmmb.2023.100480, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmmb.2023.100480</ArticleId><ArticleId IdType="pubmed">37741157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauteur PMM, Chalker VJ, Berger C, Nir-Paz R, Beeton ML, Pereyre S, et al. . ESGMAC and the ESGMAC–MyCOVID study group. Mycoplasma pneumoniae Beyond the COVID-19 pandemic: where is it? Lancet Microbe. (2022) 3:e897. doi: 10.1016/S2666-5247(22)00190-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00190-2</ArticleId><ArticleId IdType="pmc">PMC9371584</ArticleId><ArticleId IdType="pubmed">35964636</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Li T, Chen N, Kang P, Yang J. Changes of Mycoplasma pneumoniae prevalence in children before and after COVID-19 pandemic in Henan, China. J Inf Secur. (2023) 86:256–308. doi: 10.1016/j.jinf.2022.12.030, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.12.030</ArticleId><ArticleId IdType="pmc">PMC9838080</ArticleId><ArticleId IdType="pubmed">36646141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Cheng Y, Dai S, Hou D, Ge M, Zhang Y, et al. . The prevalence of Mycoplasma Pneumoniae among children in Beijing before and during the COVID-19 pandemic. Front Cell Infect Microbiol. (2022) 12:854505. doi: 10.3389/fcimb.2022.854505</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.854505</ArticleId><ArticleId IdType="pmc">PMC9103471</ArticleId><ArticleId IdType="pubmed">35573799</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur PM, Beeton ML. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae. Lancet Microbe. (2024) S2666-5247:00406–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">38008103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and Meta-analysis. JAMA Netw Open. (2022) 5:e2220949. doi: 10.1001/jamanetworkopen.2022.20949</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.20949</ArticleId><ArticleId IdType="pmc">PMC9274321</ArticleId><ArticleId IdType="pubmed">35816304</ArticleId></ArticleIdList></Reference><Reference><Citation>Loconsole D, de Robertis AL, Sallustio A, Centrone F, Morcavallo C, Campanella S, et al. . Update on the epidemiology of macrolide-resistant Mycoplasma pneumoniae in Europe: a systematic review. Infect Dis Rep. (2021) 13:811–20. doi: 10.3390/idr13030073, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr13030073</ArticleId><ArticleId IdType="pmc">PMC8482213</ArticleId><ArticleId IdType="pubmed">34562998</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi T, Ouchi K. Recent trends in the epidemiology, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae. J Clin Med. (2022) 11:1782. doi: 10.3390/jcm11071782, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071782</ArticleId><ArticleId IdType="pmc">PMC8999570</ArticleId><ArticleId IdType="pubmed">35407390</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R, Levy C, Rybak A, Angoulvant F, Ouldali N, Grimprel E. Immune debt: recrudescence of disease and confirmation of a contested concept. Infect Dis Now. (2023) 53:104638. doi: 10.1016/j.idnow.2022.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2022.12.003</ArticleId><ArticleId IdType="pmc">PMC9756601</ArticleId><ArticleId IdType="pubmed">36535583</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung C, Konya L, Su L. Postpandemic immunity debt of influenza in the USA and England: an interrupted time series study. Public Health. (2024) 227:239–42. doi: 10.1016/j.puhe.2023.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2023.12.009</ArticleId><ArticleId IdType="pubmed">38246119</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Chu C, Wei B, Lu H. Immunity debt: hospitals need to be prepared in advance for multiple respiratory diseases that tend to co-occur. Biosci Trends. (2024) 17:499–502. doi: 10.5582/bst.2023.01303</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2023.01303</ArticleId><ArticleId IdType="pubmed">38072445</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Li X, Ning W, Gong S, Yang F, Fang C, et al. . Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19. Theranostics. (2021) 11:8008–26. doi: 10.7150/thno.61832</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.61832</ArticleId><ArticleId IdType="pmc">PMC8315065</ArticleId><ArticleId IdType="pubmed">34335977</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen PR, Rybak A, Werner A, Béchet S, Desandes R, Hassid F, et al. . Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: a prospective multicentric surveillance study in France. Lancet Reg Health Eur. (2022) 22:100497. doi: 10.1016/j.lanepe.2022.100497, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100497</ArticleId><ArticleId IdType="pmc">PMC9398201</ArticleId><ArticleId IdType="pubmed">36034052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>